These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 30089216

  • 1. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.
    Liu K, Li Y, Yu B, Wang F, Mi T, Zhao Y.
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1246-1254. PubMed ID: 30089216
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
    Wang Y, Gao B, Tan PY, Handoko YA, Sekar K, Deivasigamani A, Seshachalam VP, OuYang HY, Shi M, Xie C, Goh BKP, Ooi LL, Man Hui K.
    FASEB J; 2019 Aug; 33(8):8759-8770. PubMed ID: 31022357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
    Huang DH, Jian J, Li S, Zhang Y, Liu LZ.
    Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
    Zhang R, Ai J, Wang J, Sun C, Lu H, He A, Li M, Liao Y, Lei J, Zhou F, Wu L, Liao W.
    J Transl Med; 2022 Jul 21; 20(1):325. PubMed ID: 35864529
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of short interfering RNA-mediated gene silencing of SKA1 on proliferation of hepatocellular carcinoma cells.
    Qin X, Yuan B, Xu X, Huang H, Liu Y.
    Scand J Gastroenterol; 2013 Nov 21; 48(11):1324-32. PubMed ID: 24010405
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 21; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas.
    Liu Q, Dai SJ, Li H, Dong L, Peng YP.
    Asian Pac J Cancer Prev; 2014 Dec 21; 15(20):8623-9. PubMed ID: 25374179
    [Abstract] [Full Text] [Related]

  • 16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.
    Oncotarget; 2015 Dec 01; 6(38):41383-97. PubMed ID: 26515591
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J, Liang R, Bai T, Lin Y, Mai R, Wei M, Ye X, Li L, Wu F.
    J Exp Clin Cancer Res; 2018 Sep 03; 37(1):212. PubMed ID: 30176896
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.